130-year old Amrutanjan Healthcare was bestowed with the esteemed Best Healthcare Brands felicitation at the 6th edition of The Economic Times Best Healthcare Brands event held recently . The company was chosen out of 1,000 brands after a meticulous and rigorous selection process. This recognition is particularly prestigious as only a limited number of over-the-counter (OTC) brands managed to meet the criteria.
At the forefront of its wide portfolio is its flagship brand, Amrutanjan, a specialist in pain management that formulates high-quality products using scientifically proven natural ingredients. The company holds the distinction of being a pioneer in introducing innovative formats like roll-on for head and body ache, as well as the first to introduce a hydrogel pain patch, offering convenient solutions for consumers. The company is committed to ethical business practices and takes a firm stance against the use of chemicals such as Diclofenac, which can have harmful side effects and pose risks to the environment.
S. Sambhu Prasad, Chairman and Managing Director Amrutanjan Healthcare Limited said, “We are deeply honored to be recognized as one of the Best Healthcare Brands. This achievement is a testament to Amrutanjan’s untiring dedication to offering exceptional healthcare solutions that significantly improve the lives of our valued consumers. We extend our heartfelt appreciation to our dedicated team, loyal customers, and supportive partners, who have played an integral role in our journey to success. As we move forward, we will remain steadfast in our commitment to making a profound impact in the lives of individuals through our trusted and high-quality healthcare products.”
In addition to pain management offerings, Amrutanjan Healthcare provides products in other categories such as cold and congestion remedies (Relief Cold rub, Inhaler & Cough syrup), beverages (Fruit-based rehydration drink Electro+ and Fruitnik), and women’s hygiene products (Comfy Snug Fit sanitary napkins).
Gross Sales for FY 22-23 for Amrutanjan was Rs. 426.22 Cr while PAT for the same period was Rs. 39.83 Cr. Sales from e-commerce grew from Rs. 9.55 Cr in FY 21-22 to Rs. 10.85 in FY 22-23.
